Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly.

Published in: Clinical and experimental vaccine research (2017)

PCV13+IIV3 and PPV23+IIV3 demonstrated similar immunogenicity and safety in the elderly.

Keyphrases